DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Betoptic (Betaxolol Hydrochloride Ophthalmic) - Side Effects and Adverse Reactions

 
 



ADVERSE REACTIONS

The following adverse reactions have been reported in clinical trials with BETOPTIC Ophthalmic Solution.

Ocular

Discomfort of short duration was experienced by one in four patients, but none discontinued therapy; occasional tearing has been reported. Rare instances of decreased corneal sensitivity, erythema, itching sensation, corneal punctate staining, keratitis, anisocoria, edema, and photophobia have been reported.

Additional medical events reported with other formulations of betaxolol include blurred vision, foreign body sensation, dryness of the eyes, inflammation, discharge, ocular pain, decreased visual acuity, and crusty lashes.

Systemic

Systemic reactions following administration of BETOPTIC Ophthalmic Solution 0.5% or BETOPTIC S Ophthalmic Suspension 0.25% have been rarely reported. These include:

Cardiovascular

Bradycardia, heart block and congestive failure.

Pulmonary

Pulmonary distress characterized by dyspnea, bronchospasm, thickened bronchial secretions, asthma and respiratory failure.

Central Nervous System

Insomnia, dizziness, vertigo, headaches, depression, lethargy, and increase in signs and symptoms of myasthenia gravis.

Other

Hives, toxic epidermal necrolysis, hair loss and glossitis.



REPORTS OF SUSPECTED BETOPTIC SIDE EFFECTS / ADVERSE REACTIONS

Below is a sample of reports where side effects / adverse reactions may be related to Betoptic. The information is not vetted and should not be considered as verified clinical evidence.

Possible Betoptic side effects / adverse reactions in 71 year old female

Reported by a health professional (non-physician/pharmacist) from Russian Federation on 2011-10-11

Patient: 71 year old female

Reactions: Eye Irritation, Wrong Drug Administered, Visual Acuity Reduced, Ocular Discomfort, Corneal Oedema, Corneal Epithelium Defect, Blister

Suspect drug(s):
Betoptic
    Dosage: 1 gtt bid, ophthalmic
    Indication: Open Angle Glaucoma
    Start date: 2011-03-01
    End date: 2011-06-02

Travatan 0.004% Ophthalmic Solutioin (Travatan) 1 GTT
    Dosage: 1 gtt, qd, ophthalmic
    Indication: Open Angle Glaucoma
    Start date: 2011-06-02



Possible Betoptic side effects / adverse reactions in 78 year old male

Reported by a health professional (non-physician/pharmacist) from Croatia (Local Name: Hrvatska) on 2012-03-05

Patient: 78 year old male

Reactions: Cardiac Failure, Extrasystoles, Drug Interaction, Arrhythmia

Suspect drug(s):
Betoptic
    Dosage: (1 gtt qid ophthalmic)
    Indication: Glaucoma
    Start date: 2009-12-01
    End date: 2010-04-21

Vistagan EYE Drops (Vistagan Liquifilm) (Not Specified)
    Dosage: (1 gtt qid ophthalmic)
    Indication: Glaucoma
    Start date: 2009-12-01
    End date: 2010-04-21

Other drugs received by patient: Lumigan; Refresh-Contacts



Possible Betoptic side effects / adverse reactions in 78 year old male

Reported by a pharmacist from Croatia (Local Name: Hrvatska) on 2012-04-01

Patient: 78 year old male

Reactions: Cardiac Failure, Extrasystoles, Drug Interaction, Arrhythmia

Suspect drug(s):
Betoptic
    Dosage: 1 gtt, qid
    Indication: Glaucoma
    Start date: 2009-12-01
    End date: 2010-04-21

Vistagan Liquifilm 0.5% EYE Drops
    Dosage: 1 gtt, qid
    Indication: Glaucoma
    Start date: 2009-12-01
    End date: 2010-04-21

Other drugs received by patient: Lumigan; Refresh Contacts EYE Drops



See index of all Betoptic side effect reports >>

Drug label data at the top of this Page last updated: 2007-02-06

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017